← All trials
NCT01049256
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2008
- Primary completion
- Apr 30, 2010
- Completion date
- Oct 31, 2010
- First posted
- Jan 14, 2010
- Last posted
- Jan 14, 2010
- Enrollment
- 45
- Arms / groups
- — / —
- Source
- AACT · ctgov ingestion
Sponsors
- Imperial College LondonLead sponsor
- Imperial College LondonOverall official - principal investigator
- Imperial College LondonSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.